Literature DB >> 24680584

Body mass index, physical activity, and mortality in women diagnosed with ovarian cancer: results from the Women's Health Initiative.

Yang Zhou1, Rowan Chlebowski2, Michael J LaMonte3, Jennifer W Bea4, Lihong Qi5, Robert Wallace6, Sayeh Lavasani7, Brian W Walsh8, Garnet Anderson9, Mara Vitolins10, Gloria Sarto11, Melinda L Irwin12.   

Abstract

BACKGROUND: Ovarian cancer is often diagnosed at late stages and consequently the 5-year survival rate is only 44%. However, there is limited knowledge of the association of modifiable lifestyle factors, such as physical activity and obesity on mortality among women diagnosed with ovarian cancer. The purpose of our study was to prospectively investigate the association of (1) measured body mass index (BMI), and (2) self-reported physical activity with ovarian cancer-specific and all-cause mortality in postmenopausal women enrolled in the Women's Health Initiative (WHI).
METHODS: Participants were 600 women diagnosed with primary ovarian cancer subsequent to enrollment in WHI. Exposure data, including measured height and weight and reported physical activity from recreation and walking, used in this analysis were ascertained at the baseline visit for the WHI. Cox proportional hazard regression was used to examine the associations between BMI, physical activity and mortality endpoints.
RESULTS: Vigorous-intensity physical activity was associated with a 26% lower risk of ovarian cancer specific-mortality (HR=0.74; 95% CI: 0.56-0.98) and a 24% lower risk of all-cause mortality (HR=0.76; 95% CI: 0.58-0.98) compared to no vigorous-intensity physical activity. BMI was not associated with mortality.
CONCLUSIONS: Participating in vigorous-intensity physical activity, assessed prior to ovarian cancer diagnosis, appears to be associated with a lower risk of ovarian cancer mortality.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Exercise; Mortality; Obesity; Ovarian cancer; Physical activity; Weight

Mesh:

Year:  2014        PMID: 24680584      PMCID: PMC4064800          DOI: 10.1016/j.ygyno.2014.01.033

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.304


  33 in total

1.  Associations of light, moderate, and vigorous intensity physical activity with longevity. The Harvard Alumni Health Study.

Authors:  I M Lee; R S Paffenbarger
Journal:  Am J Epidemiol       Date:  2000-02-01       Impact factor: 4.897

Review 2.  Obesity and ovarian cancer survival: a systematic review and meta-analysis.

Authors:  Melinda M Protani; Christina M Nagle; Penelope M Webb
Journal:  Cancer Prev Res (Phila)       Date:  2012-05-18

3.  Physical activity and survival in postmenopausal women with breast cancer: results from the women's health initiative.

Authors:  Melinda L Irwin; Anne McTiernan; JoAnn E Manson; Cynthia A Thomson; Barbara Sternfeld; Marcia L Stefanick; Jean Wactawski-Wende; Lynette Craft; Dorothy Lane; Lisa W Martin; Rowan Chlebowski
Journal:  Cancer Prev Res (Phila)       Date:  2011-04

4.  Pre- and post-diagnosis body mass index, weight change, and ovarian cancer mortality.

Authors:  Yang Zhou; Melinda L Irwin; Harvey A Risch
Journal:  Gynecol Oncol       Date:  2010-11-23       Impact factor: 5.482

5.  Physical activity and survival after breast cancer diagnosis.

Authors:  Michelle D Holmes; Wendy Y Chen; Diane Feskanich; Candyce H Kroenke; Graham A Colditz
Journal:  JAMA       Date:  2005-05-25       Impact factor: 56.272

6.  Impact of obesity on operative morbidity and clinical outcome in primary epithelial ovarian cancer after optimal primary tumor debulking.

Authors:  Christina Fotopoulou; Rolf Richter; Elena-Ioana Braicu; Marc Kuhberg; Aarne Feldheiser; Joerg C Schefold; Werner Lichtenegger; Jalid Sehouli
Journal:  Ann Surg Oncol       Date:  2011-03-11       Impact factor: 5.344

7.  Dietary habits and risk of ovarian cancer death in a large-scale cohort study (JACC study) in Japan.

Authors:  Fumio Sakauchi; M M H Khan; Mitsuru Mori; Tatsuhiko Kubo; Yoshihisa Fujino; Sadao Suzuki; Shinkan Tokudome; Akiko Tamakoshi
Journal:  Nutr Cancer       Date:  2007       Impact factor: 2.900

Review 8.  A literature review of the social and psychological needs of ovarian cancer survivors.

Authors:  Katherine B Roland; Juan L Rodriguez; Jennifer Rees Patterson; Katrina F Trivers
Journal:  Psychooncology       Date:  2013-06-13       Impact factor: 3.894

9.  Obesity paradox in a cohort of 4880 consecutive patients undergoing percutaneous coronary intervention.

Authors:  Claire E Hastie; Sandosh Padmanabhan; Rachel Slack; Alastair C H Pell; Keith G Oldroyd; Andrew D Flapan; Kevin P Jennings; John Irving; Hany Eteiba; Anna F Dominiczak; Jill P Pell
Journal:  Eur Heart J       Date:  2009-08-17       Impact factor: 29.983

10.  Influence of body mass index on prognosis in gynecological malignancies.

Authors:  Karsten Münstedt; Mathias Wagner; Uwe Kullmer; Andreas Hackethal; Folker E Franke
Journal:  Cancer Causes Control       Date:  2008-04-08       Impact factor: 2.506

View more
  25 in total

1.  Physical activity communication between oncology providers and patients with early-stage breast, colon, or prostate cancer.

Authors:  Kirsten A Nyrop; Allison M Deal; Grant R Williams; Emily J Guerard; Mackenzi Pergolotti; Hyman B Muss
Journal:  Cancer       Date:  2015-11-13       Impact factor: 6.860

2.  A randomized trial of diet and physical activity in women treated for stage II-IV ovarian cancer: Rationale and design of the Lifestyle Intervention for Ovarian Cancer Enhanced Survival (LIVES): An NRG Oncology/Gynecologic Oncology Group (GOG-225) Study.

Authors:  Cynthia A Thomson; Tracy E Crane; Austin Miller; David O Garcia; Karen Basen-Engquist; David S Alberts
Journal:  Contemp Clin Trials       Date:  2016-07-06       Impact factor: 2.226

3.  Perirenal Adiposity is Associated With Lower Progression-Free Survival From Ovarian Cancer.

Authors:  Yan Zhang; Adriana M Coletta; Pamela K Allen; Aaroh M Parikh; Matthes Cox-Mattin; Larissa A Meyer; Charlotte C Sun; Karen M Basen-Engquist; Karen H Lu; Ann H Klopp
Journal:  Int J Gynecol Cancer       Date:  2018-02       Impact factor: 3.437

Review 4.  Epithelial ovarian cancer and recreational physical activity: A review of the epidemiological literature and implications for exercise prescription.

Authors:  Rikki A Cannioto; Kirsten B Moysich
Journal:  Gynecol Oncol       Date:  2015-03-20       Impact factor: 5.482

5.  Body weight changes in patients undergoing chemotherapy for ovarian cancer influence progression-free and overall survival.

Authors:  Marcin Mardas; Marta Stelmach-Mardas; Radosław Madry
Journal:  Support Care Cancer       Date:  2016-10-22       Impact factor: 3.603

Review 6.  Association between Body Mass Index and Cancer Survival in a Pooled Analysis of 22 Clinical Trials.

Authors:  Heather Greenlee; Joseph M Unger; Michael LeBlanc; Scott Ramsey; Dawn L Hershman
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2016-12-16       Impact factor: 4.254

7.  Participation in Physical Activity and Risk for Amyotrophic Lateral Sclerosis Mortality Among Postmenopausal Women.

Authors:  Yvonne L Eaglehouse; Evelyn O Talbott; Yuefang Chang; Lewis H Kuller
Journal:  JAMA Neurol       Date:  2016-03       Impact factor: 18.302

8.  Diet quality and survival after ovarian cancer: results from the Women's Health Initiative.

Authors:  Cynthia A Thomson; Tracy E Crane; Betsy C Wertheim; Marian L Neuhouser; Wenjun Li; Linda G Snetselaar; Karen M Basen-Engquist; Yang Zhou; Melinda L Irwin
Journal:  J Natl Cancer Inst       Date:  2014-10-21       Impact factor: 13.506

9.  Midlife Cardiorespiratory Fitness, Incident Cancer, and Survival After Cancer in Men: The Cooper Center Longitudinal Study.

Authors:  Susan G Lakoski; Benjamin L Willis; Carolyn E Barlow; David Leonard; Ang Gao; Nina B Radford; Stephen W Farrell; Pamela S Douglas; Jarett D Berry; Laura F DeFina; Lee W Jones
Journal:  JAMA Oncol       Date:  2015-05       Impact factor: 31.777

10.  Survival and clinical outcomes of patients with ovarian cancer who were treated on phase 1 clinical trials.

Authors:  Bradley R Corr; Marisa Moroney; Jeanelle Sheeder; S Gail Eckhardt; Brandon Sawyer; Kian Behbakht; Jennifer R Diamond
Journal:  Cancer       Date:  2020-07-22       Impact factor: 6.860

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.